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Abstract
The potential ofmagnetically assisted strategies within the remit of cell-based therapies is increasing,
creating newopportunities for biomedical platforms and in theﬁeld of tissue engineering and
regenerativemedicine. Among themagnetic elements approached for buildingmagnetically
responsive strategies, superparamagnetic iron oxide nanoparticles (SPIONs) represent tunable and
precise tools whose properties can bemodelled for detection, diagnosis, targeting and therapy
purposes. Themost investigated clinical role of SPIONs is as contrast imaging agents for tracking and
monitoring cells and tissues. Nevertheless,magnetic detection also includes biomarkermapping, cell
labelling and cell/drug targeting tomonitor cell events and anticipate the disruption of homeostatic
conditions and the progression of disease. Additionally, the isolation and screening techniques of cell
subsets in heterogeneous populations or of proteins of interest have been explored in amagnetic
sorting context.More recently, SPION-based technologies have been applied to stimulate cell
differentiation andmechanotransduction processes and to transport genetic or drug cargo to study
biologicalmechanisms and contribute to improved therapies.Magnetically based strategies
signiﬁcantly contribute tomagnetic tissue engineering (magTE), inwhichmagnetically responsive
actuators built frommagnetic labelled cells ormagnetic functionalized systems can be remotely
controlled and spatiallymanipulated upon the actuation of an externalmagneticﬁeld for the delivery
or target of TE solutions. SPION functionalities combinedwithmagnetic responsiveness in
multifactorialmagnetically assisted platforms can revolutionize diagnosis and therapeutics, providing
newdiagnosis and theranostic tools, encouraging regenerativemedicine approaches and having
potential formore effective therapies. This reviewwill address the contribution of SPION-based
technologies asmultifunctional tools in boostingmagnetically assisted cell-based strategies to explore
diagnostics and tracking solutions for the detection and analysis of pathologies, and to generate
improved treatments and therapies, envisioning precise and customized answers for themanagement
of numerous diseases.
1. Introduction
Advanced cell-based strategies will beneﬁt from emer-
ging knowledge on the magnetic responsiveness and
superparamagnetic iron oxide nanoparticle (SPION)
functionalities applied to clinics, boosting the devel-
opment of magnetically actuated systems to meet
improved solutions for biomedicine and regenerative
medicine demands.
SPIONs have been explored for a wide range of
biomedical applications, including magnetic reso-
nance imaging (MRI), hyperthermia and targeted drug
delivery [1–4]. Under the controlled and precise
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consequently, SPION incorporating systems) are
guided and concentrated at the desired site. The prin-
ciple behind the unique features of SPIONs relies on
their superparamagnetic behaviour, whose magnetic
responsiveness only persists as long as the MF is being
applied, allowing a real-time non-invasive follow-up
treatment. Moreover, magnetism-based approaches
allow the remote tracking, control, monitoring and/
or stimulation of SPIONs and/or SPION-incorporat-
ing systems, offering new perspectives and solutions
either in diagnostics or therapeutics.
In cell-based strategies, SPIONs with a magnetic
core of magnetite (Fe3O4) or maghemite (Fe2O3) are
often polymer coated to improve their biocompat-
ibility and their structural and colloidal stability, while
providing functional groups for bioactive molecule
conjugation [5] and/or ligands for targeting cells or
tissues.
SPIONs are considered to be non-cytotoxic under
100 μg ml−1, easily cleared via endogenous metabolic
iron pathways and metabolized into its elements [6]
and/or eliminated by kidney excretion [7]. Many stu-
dies have investigated SPION uptake by different cell
types without evidence of a pejorative cellular
response [8, 9], suggesting the applicability of these
particles for bioengineering and regenerativemedicine
approaches.
Smart systems integrating SPIONs anticipate the
development of detection platforms able to image,
guide and activate therapeutic cells combining diag-
nostics and therapeutics. Moreover, magnetically
assisted systems can also be applied in pharmacother-
apy as cargo vehicles of bioagents or drugs, assisting
the development of predictive in vitro disease models
to be further used as screening platforms of candidate
treatments toward patient customization therapies.
Magnetic actuators also enable cell-based thera-
pies to be guided by ﬁnely tuning the cell phenotype
and behaviour inﬂuencing proliferation, differentia-
tion and selective protein expression with magnetic
actuation [10–12], or via the magnetic-enhanced
transfection of genes of interest [13]. In this sense,
SPION technologies hold potential in the design of
biomolecular solutions with a direct role in biological
processes, inﬂuencing or correcting the biological
mechanisms involved in abnormal or undesired
responses that lead to disease or to failure in the regen-
eration process, thus envisioning a new window of
opportunity for customized treatments and improved
healthcare.
In summary, SPION-based technologies con-
stitute a holistic, integrated and versatile platformwith
potential diagnostic and therapeutic actions to man-
age numerous diseases and revolutionize regenerative
medicine, anticipating personalized medicine solu-
tions (ﬁgure 1). This review will address the different
directions of SPION-based technologies as multi-
functional tools in magnetically assisted diagnosis and
therapeutic strategies, focusing on tissue engineering
and regenerativemedicine applications.
2. SPIONs as diagnostic tools for cell-based
therapies
The development of effective treatment for injury or
disease could beneﬁt from combinations of suitable
imaging and detection methods for differential diag-
nosis. Diagnosis is often challenging and demands
complementary and accurate information to allow
personalized medical decisions about treatment and
prognosis to bemade.
SPIONs have been explored as MRI contrast
agents and as biosensors for the identiﬁcation of cells,
tissues and biomarkers associated with both healthy
and diseased conditions (ﬁgure 2).
2.1. Imaging
Medical imaging techniques such as MRI, x-ray-based
computed tomography (x-ray CT), positron emission
tomography (PET), single photon emission computed
tomography (SPECT), ﬂuorescence imaging and
ultrasound have become available to image the anat-
omy and physiological processes of the body, both
healthy and diseased. Among them, MRI is a powerful
medical diagnostic tool that lacks ionizing radiation
and allows one to non-invasively image cells and
tissues with excellent resolution and excellent tissue
penetration depth [14]. To increase the sensitivity of
MRI images, contrast enhancing agents are commonly
used. These can be divided into T1 and T2 contrast
agents. The ﬁrst shorten the longitudinal relaxation
times resulting in the brightening (positive contrast) of
surrounding tissues, whereas the latter shorten the
transverse relaxation times resulting in darkened
(negative contrast) areas.
Gadolinium (Gd)-based T1 contrast agents were
the ﬁrst generation of contrast agents used to brighten
tissues in MRI images. However, emerging research
suggests that these agents may accumulate in the brain
and have been reported to induce nephrotoxicity
[15, 16]. SPIONs, primarily used as negative (T2) con-
trast agents, have shown the potential to replace Gd-
based contrast agents due to their lower toxicity and
improved biocompatibility and became the second
generation ofMRI contrast agents [17]. Several SPION
formulations, such as Lumiren® (ferumoxsil), Abdos-
can® (ferristene), Feridex® (ferumoxide), Resovist®
(ferucarbotran), and Combidex® (ferumoxtran-10),
have attained approval for clinical use as MRI contrast
agents, allowing the imaging of different tissues and
organs (bowel, liver, spleen, lymph node) and thus
contributing to the diagnostic of several diseases
including cancer, cardiovascular and neurological
[18–20]. Combidex® is an ultrasmall SPION (size
20–40 nm) coated with dextran that has been used for
lymph node imaging. These SPIONs are able to
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extravasate from the vasculature to the interstitial
space where they are transported to the lymph nodes.
The lack of SPIONs in lymph nodes has been asso-
ciated with the presence of metastases [18]. Another
SPION, Feraheme® (ferumoxytol), which was origin-
ally developed for iron deﬁciency treatment in adult
patients with chronic kidney disease, is currently
under investigation for the detection of inﬂammatory
lesions (clinicaltrials.gov). More recently, extremely
small magnetic iron oxide nanoparticles (ES-
MIONPs,<5 nm) have been suggested as the probable
next generation of MRI contrast agents with the
potential to replace Gd-based methods as T1 contrast
agents [17, 21]. Along with a better biocompatibility,
the hydrodynamic diameter of ES-MIONP is larger
than that of Gd-based agents, and consequently, the
kidney and liver clearance of ES-MIONPs is slower,
thus providing a longer imaging timewith higher reso-
lution. Moreover, ES-MIONP clearance from the
body (24 h) is still faster than SPIONs [17].
The magnetic labelling of cells, involving the com-
bination of cells withmagnetic elements, is an essential
in vitro procedure and a useful tool to trace and pro-
vide information about therapeutic cells in vivo, so as
to understand the complex role and interactions of
implanted cells also concerning safety applications
[22–24]. In the work of Swaminathan et al, SPION-
labelled bone marrow derived from mesenchymal
stem cells (BM-SMCs) were guided to the abdominal
aortic aneurysm wall through magnetic ﬁeld actua-
tion, showing that SPION labelling is non-cytotoxic
and does not adversely impact the phenotype or elas-
togenesis by BM-SMCs [24].
More complex approaches have been developed,
which highlight SPION technology with the prog-
nostic value in theranostic platforms. Engineering the
SPION surface and playing with their properties
enables the creation of complex diagnostic units,
allowing more efﬁcient detection and treatment
action.
Figure 1.The features of SPIONs and their contribution to cell-based strategies aiming at clinical approaches.
Figure 2.A schematic representation ofmagnetically assisted strategies formedical diagnosis applications: (a) imaging and (b)
biosensing. InMRI imaging (a) SPIONs are T1 contrast agents able to shorten the longitudinal relaxation time, resulting in the
brightening (positive contrast) of surrounding tissues, while ES-MIONPs are T2 contrast agents, which are able to shorten the
transverse relaxation time resulting in the darkening (negative contrast) of surrounding tissues. Legend: SPIONs—superparamagnetic
iron oxide nanoparticles; ES-MIONPs—extremely smallmagnetic iron oxide nanoparticles.
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With recognition ligands conjugated onto their sur-
faces, SPIONs can selectively bind to biological entities,
including nucleic acids, proteins, viruses, bacteria and
eukaryotic cells. Such magnetically labelled targets can
be readily distinguished from the remaining sample
constituents, because of the intrinsically low magnetic
susceptibility of biological objects [25]. Thus, by the
magnetization of stem cells that incorporate SPIONs,
one might allow for real-time follow-upmonitoring by
MRI, for example, as a detection tool, but with ther-
anostic revenues, allowing real-time stimulation
(mechano-magnetic, drug release) or therapeutic
action (drug or gene delivery), and online reports on the
engineered system performance (degradation, actua-
tion, temperature or pH levels as an indirect mean to
assess local inﬂammation). The conjugation of ligands
on the SPION surface also allows healthy or diseased
tissue to be speciﬁcally targeted. For example, HER2 is a
highly expressed marker on breast and ovarian cancer
that combines with magnetoliposomes, forming anti-
HER2-magnetoliposome complexes for intelligent
MRI [26]. The functionality of this strategy is demon-
strated by cellular iron uptake and ex vivo imaging [26].
Since patient treatment depends on individual respon-
ses to speciﬁc biomarkers, targeting imaging may con-
tribute to the detection and prediction of individual
patient response and customization of the treatment.
In multimodality imaging approaches, SPIONs
are combined with other imaging agents such as ﬂuor-
escent dyes or radionuclides, which results in an
increased amount of complementary information that
can beneﬁt more patient-oriented treatment. In order
to locate SPIONs within glioma U251 cells, the nano-
particles were functionalized with the tumour-speciﬁc
ligand folic acid (FA) and also labelled with ﬂuorescein
isothiocyanate (FITC) [27]. SPIONs-FA-FITC were
effectively internalized by the cells and visualized with
MRI, holding promising perspectives for providing
dual-modal imaging as non-toxic and target-speciﬁc
vehicles toward human brain tumour treatment.
SPIONs can also be combined with bioactive mole-
cules with therapeutic value to treat a disease or a patho-
logical condition. Doxorubicin (DOX), a drug used in
oncology therapies, was encapsulated inpolydopamine-
coated SPIONs, which were speciﬁcally designed for
MRI detection and cell targeting drug delivery [28]. The
particles demonstrated a good negative contrast effect
for MRI detection, and achieved high efﬁciency of drug
delivery by quick degradation in a reductive environ-
ment due to the cleavage of the disulﬁde linkages.More-
over, the cellular uptake and cytotoxicity of the DOX-
loaded SPIONs against HeLa cells, causing their death
upon internalization, demonstrated the effectiveness of
the developed system towards theranostic strategies.
Since the application of external magnets may
limit the targeting of deep tissues or organs as their
ﬁeld strength and ﬁeld gradient decrease exponentially
with distance from the surface, the monitoring or
targeting of magnetic labelled systems can be
alternatively performed usingmagnetic resonance tar-
geting. This approach uses the magnetic ﬁeld gradient
coils inherent to all MRI systems, to steer magnetic
particles (or the systems containing them) to a target
site [29]. Clinically available MRI scanners are able to
detect the location of magnetically labelled macro-
phages carrying an oncolytic virus into primary and
metastatic tumour sites, and non-invasively conﬁrm
their anatomical position inmice [30].
An emerging imaging technique that is increas-
ingly attracting attention is magnetic particle imaging
(MPI). MPI is based on the response of SPIONs to
alternating magnetic ﬁelds and can speciﬁcally deter-
mine their spatial distribution and local concentra-
tion. Unlike MRI, SPIONs are the only source of the
signal, and thus the only visualized elements in MPI.
Resovist®, a clinically approved liver MRI contrast
agent, is the standard MPI tracer; however, studies on
the development of improved tracers to better ﬁt MPI
purposes are currently underway [31, 32]. MPI is
expected to provide high sensitivity and high spatial
resolution [31]. Currently, it is under evaluation in
preclinical research studies in vascular imaging,
tumour imaging, targeted imaging, transplanted stem
cell tracking, and to image medical devices such as
guidewires and PTA catheters [33].
2.2. Biosensing
Biosensing is an effective diagnostic platform for the
detection of clinically relevant disease biomarkers,
pathogens and cells with high sensitivity, which can
enable early disease diagnosis and the real-time mon-
itoring of individual responses to treatments. Biosen-
sing strategies focus on monitoring biological events
and on the detection and quantiﬁcation of analytes such
as ligands, proteins or other molecules with bioactive
action, using a biosensor that converts the biological
response into a processable and quantiﬁable signal [34].
A biosensor typically comprises three elements: (i) a
bioreceptor that binds speciﬁcally to the analyte; (ii) an
interface where a biological event occurs and gives
origin to a signal that is picked up by a transducer; and
(iii) an electronic system where the transducer signal is
converted to an electronic signal and ampliﬁed by a
detector circuit using an appropriate reference and sent
for conversion into a physical parameter describing the
biological event under investigation [34].
The application of magnetic nanoparticles
(MNPs) in biosensing provides enhanced sensitivity,
lower limit of detection, higher signal-to-noise ratio
and a shorter analysis time [35, 36]. Moreover, as most
biological samples have no magnetic background,
unlike other biosensing platforms, highly sensitive
measurements can be performed in turbid or
otherwise visually obscured samples with minimal
processing [37]. MNPs can be immobilized on the sur-
face of the transducer or function as free moving
magnetic labels forming analyte-MNP conjugates,
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followed by their attraction by an externalMF onto the
transducer [36, 38].
SPION-based biosensors have been developed
using different transduction principles: electro-
chemical, optical, piezoelectric and magnetic
ﬁeld [36, 37].
An electrochemical cytosensing approach was
developed by Zheng et al [39] for the selective detec-
tion of leukaemia cells and the quantitative evaluation
of cell surface receptors DR4 and DR5, which are
important diagnostic markers for guiding death-
receptor-based leukaemia treatment. The fabricated
sensor was based on the co-immobilization of both
recombinant human TRAIL—a ligand that speciﬁ-
cally binds to DR4 and DR5 causing apoptosis of leu-
kaemia cells—and horseradish peroxidase (HRP) on
gold-nanoparticle-decorated magnetic Fe3O4 beads.
The presented approach achieved a detection limit as
low as ∼40 cells and allowed the quantitative char-
acterization of the DR4/DR5 expression on leukaemia
cells. The developed platform was considered to be of
great value for the early diagnosis of human leukaemia
and the monitoring of therapeutic effects on leukae-
mia patients.
Considering that the early detection of cardiac bio-
markers such as C-reactive protein (CPR), is essential
for cardiovascular diseases, Zhou et al [40] developed an
ultrasensitive piezoelectric immunosensor based on a
capture probe of CPR labelled Fe3O4 nanoparticles. The
capture probe increased theCRP concentration through
magnetic separation, thus amplifying the CPR signal,
and also allowing ready immobilization on the electrode
by an external magnet. The reported detection limit was
0.3 pgml−1, which is lower than traditional immu-
noassay values. The sensor can be regenerated and
repeatedly used, representing a versatile technology for
the detectionof cardiacmarkers.
SPIONs have also been used to amplify the signal
developed by surface plasmon resonance (SPR)
spectroscopy in an optical-based biosensor [41]. The
experimental results demonstrate that anti-thrombin
aptamer-Fe3O4 nanoparticle conjugates greatly enhance
the sensitivity of the SPR sensor for the detection of
thrombin, and hold the potential to be extended to the
detectionof other biomolecules of interest.
Hathaway et al [42] developed a magnetic-ﬁeld-
based biosensor by using a superconducting quantum
interference device (SQUID) system for the detection
of MCF7/Her2-18 breast cancer cells using an anti-
Her2 antibody conjugated to carboxyl-functionalized
SPIONs. The authors demonstrated that the system
was able to detect as few as 1million optimally labelled
breast cancer cells at a depth of 4.5 cm in a breast
phantommodel.
Biosensing remains quite an exciting platform for
detection and diagnosis. Although currently explored
systems relate to single analyte detection, it is likely
that biosensing devices will evolve toward multi-
analytic detection systems with improved sensitivity
and selectivity. Improved systems will also beneﬁt
from miniaturization, which will lead to cost reduc-
tion in the detection and quantiﬁcation of biomarkers,
thusmaking them cost effective to compete with com-
mercially available biosensing tools. Future magnetic-
based biosensors are also expected to be easily handled
without requiring special equipment, and if desired,
be integrated into more complex devices such as
microﬂuidic chips. They can also be computer con-
trolled, monitoring real-time events or functional
responses in order to study biological mechanisms to
be assessed in in vitromodels.
3. SPIONs as tools for improving cell
functionality in cell-based therapies
A growing number of studies show the applicability of
magnetic actuators in improved cell separation techni-
ques, receptor-mediated targeting, activation of mole-
cular pathways (via cellular receptor activation), the
transport and delivery of gene and pharmacological
cargoes and the integration of magnetic responsive
systems. These tools with bioinstructive action have
been investigated for regenerative medicine and TE
approaches (ﬁgure 3).
3.1. Immunemagnetic sorting/separation
The sorting of biological targets, such as cells or
proteins, from heterogeneous pools may result in
more efﬁcient usage in speciﬁc applications or thera-
pies. The selection of cells from a crude population
with a basis on magnetic separation (ﬁgure 3(a)) is
possible with a recurrence of magnetic elements such
as SPIONs, unless the cells possess an intrinsic
magneticmoment, which is the case for red blood cells
(as the cytoplasm of erythrocytes is rich in hemoglo-
bin, an iron-containing biomolecule), and magneto-
tactic bacteria (these bacteria have organelles called
magnetosomes that containmagnetic crystals).
Immunomagnetic cell isolation relies on the cou-
pling of magnetic particles with antibodies, enabling a
cell subpopulation to be selected with putative inter-
est. Brieﬂy, the immunomagnetic beads are con-
jugated with the antibody of interest and incubated
with cells. Subsequently, the bead-bound cells are
attracted to the magnet and separated from the unla-
belled cells. SPIONs for cell separation should be che-
mically stable and should not aggregate in the media.
Moreover, magnetic particles should also possess low
magnetic remanence after having been subjected to
the magnetic ﬁeld and not bind to cells non-speciﬁ-
cally. Finally, and anticipating in vivo studies, SPIONs
for cell isolation should have dimensions which mini-
mize phagocytosis [43].
Previous studies by our research group [44–50]
and others [51, 52] show that human adipose stem
cells (hASCs) are composed of subpopulations with
distinct differentiation potential, which highlights
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the differential role of subpopulations to lineage
commitment and toward (autologous) tissue-oriented
applications. hASCs cell subpopulations have been
successfully isolated using commercially available
superparamagnetic Dynabeads®, precoated with
several antibodies of interest, for instance SSEA-4,
Figure 3.A schematic representation ofmagnetically assisted cell-based strategies envisioned for therapeutic applications: (a) immune
magnetic sorting/separation; (b)magnetic cell receptor activation ofmechanotransduction pathways; (c)magnetic bioactive agent
delivery: (c1) drug delivery and (c2) gene delivery; (d)magnetic cell sheets; and (e)magnetic responsive scaffolds. Legend: ECM—
extracellularmatrix.
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STRO-1 and CD29. These subpopulations demon-
strate dissimilar osteogenic and chondrogenic differ-
entiation potential [44–47]. Moreover, the SSEA-4
subpopulation of the cells gives rise to both micro-
vascular endothelial-like and osteoblastic cells [47].
More recently, a subset of hASCs that is positive for
tenomodulin (TNMD) expression was investigated for
tenogenic lineage commitment [50]. TNMD+ hASCs
demonstrated increased tenogenic potential when
compared to the crude population.
This is an effective methodology based on magn-
etic actuated tools for the separation of distinctive
stem cell subpopulations within a crude population
that might be used with higher efﬁciency in lineage-
speciﬁc regeneration therapies. To sum up, the fact
that the cells within the heterogeneous pool respond
differently and with improved differentiation cap-
ability toward crude populations confers an added
therapeutic value to cell screening and sorting cell-
based strategies in the repair of tissue injuries.
Using the same principle of immunomagnetic
separation, themagnetic activated cell sorting (MACS)
technique, combines the antibody-SPION labelling of
cells with MACS sorter columns by means of a high-
gradient magnetic ﬁeld composed of permanent mag-
nets within the columns. The columns are normally
designed for positive selection, but can also be used for
the depletion of strongly magnetically labelled cells.
Recently, Jia et al reported this technique for the pur-
iﬁcation ofMSCs expressing CD90 from synovial ﬂuid
(hSF-MSCs) at the knee joint [53]. MSCs have been
found to maintain the MSC phenotype, stemness and
differentiation potential. However, for in vitro diag-
nostics and in cell-based therapies, it might be desir-
able to screen multiple targets simultaneously,
challenging throughput sorting. Having this in mind,
Adams et al reported a study using a multi-target
magnetic activated cell sorter (MT-MACS) andmicro-
ﬂuidics technology to achieve the spatially-addressable
sorting of multiple target cell types in a continuous-
ﬂowmanner [54]. Speciﬁcally, two magnetic tags with
distinct saturation magnetization and size were used.
The hydrodynamic force produced from the laminar
ﬂow together with the magnetophoretic force pro-
duced by patterned ferromagnetic structures within
the microchannel resulted in the selective puriﬁcation
of two types of target cell into multiple independent
outlets [54].
MACS offers the advantage of sorting a high
number of events/cells, which can be combined with
other parameters such as cell size and complexity,
allowing the high-throughput separation of magneti-
cally labelled targets. Regardless of the method
used, the selection of deﬁned cellular populations
will likely induce a more tissue-speciﬁc oriented
response, leading to cell-based strategies with tissue
targeted commitment.
3.2. Activation ofmechanotransduction pathways
viamagnetic actuation
The MNP-mediated activation of signaling pathways
may trigger the production of speciﬁc biomolecules,
such as enzymes or transcription factors, ultimately
resulting in altered gene expression, inﬂuencing cellu-
lar processes such as proliferation, apoptosis, differ-
entiation, inﬂammation or migration. The activation
of signal pathways by MNPs and the understanding of
the underlying signalling machinery is increasingly
important for knowledge of tissue biology and to
predict tissue responses to changes in environmental
mechanical stimuli. Therefore, the control of biologi-
cal responses using MNPs might be desirable in a
clinical scenario, which can be synergistically com-
bined with the application of MF actuators, such as
magnetotherapy devices, leading to improved out-
comes in cell-based therapies.
Unveiling complex mechanisms as the mechan-
otransduction pathways of cells inmusculoskeletal tis-
sues can be achieved by tailoring MNPs with receptor
ligands or mechanosensitive binding antibodies
(ﬁgure 3(b)) [55]. MNPs respond to the application of
an oscillating magnetic ﬁeld, delivering mechanical
stimuli directly to individual cells, speciﬁcally target-
ing particularmechanoresponsive cell receptors.MNP
technology and the actuation of oscillating magnetic
ﬁelds have been extensively utilized to remotely acti-
vate different signalling pathways, through stimula-
tion of the transmembrane ion channel stretch
activated potassium channel (TREK-1), the (integrin)
RGD-binding domains [56, 57], the platelet-derived
growth factor receptor (PDGFR) [58], and frizzled
receptors [59, 60]. These constitute different examples
of mechanically responsive targets that have been
explored in the osteogenic differentiation of hMSCs.
Recently, this biomagnetic technology has been
demonstrated in the targeting of the TGF-β/Smad2/3
pathway involved in the mechanotriggering of stem
cell tenogenesis [61].
3.3. Target/delivery of bioactive agents
The role of SPIONs in regenerative medicine and
disease management can be further extended to the
possibility of targeting and delivering bioactive agents,
modulating the release proﬁle of the agent and
assessing the therapeutic efﬁcacy of a delivered agent
in real-time promoting amore efﬁcient treatment.
Bioactive agents such as chemotherapeutic drugs,
radionuclides, anti-inﬂammatory agents or ther-
apeutic peptides/antibodies can be loaded on or
within the organic or inorganic surface coating of
SPIONs (by a covalent bond or physical interactions),
or trapped within complex systems such asmagnetoli-
posomes, microparticulate systems or hydrogel matri-
ces [28, 62–66].
The actuation of an external MF can actively guide
the bioactive agents to a speciﬁc anatomical site to be
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retained (ﬁgure 3(c1)), and trigger a remote-con-
trolled release that can be modulated according to the
treatment requirements [67, 68].
Static or low frequency MFs trigger bioactive agent
release by mechanical disruption of the magnetic carrier,
with negligible or non-existent temperature effects
[66, 67, 69]. The application of an oscillating MF (33Hz,
0.18 T) in alginate/chitosan beads containing SPIONs
and insulin prepared by Finotelli et al [69] increased insu-
lin release three-fold relative to a no-ﬁeld control. This
was a promising result envisioning the clinical applica-
tions of the controlled release of insulin following a sub-
cutaneous implant approach. SPION incorporation into
hydrogelmatrices has also been explored as a delivery sys-
tem. Hydrogels contain a large amount of water, which
gives them physical similarity to tissue, high biocompat-
ibility and the ability to encapsulate hydrophilic bioactive
agents and even cells. Staticmagneticﬁelds (magnets) can
deform the hydrogels containing the SPION (ferrogels)
network resulting in controlled drug (mitoxantrone),
biomacromolecules suchasDNAandcell release [70, 71].
Studies by Campbell et al [72] suggest the combina-
tion of thermal responsive microgels and SPIONs to
enhance bioactive agent release by the actuation of a
high-frequency MF that increases the temperature
locally. SPIONs containing hydrogels obtained by
copolymerizing N-isopropylacrylamide (NIPAM) with
N-isopropylmethacrylamide (NIPMAM) enhanced the
release of FITC-dextran four-fold, and was used as a
therapeuticmodel for tracking release, when exposed to
an alternating magnetic ﬁeld (200 kHz) relative to the
off state [72]. The actuation of the alternating magnetic
ﬁeld induced an increment in temperature from 37 °C
to 43 °C. Moreover, a pulsatile release was externally
controlled over multiple cycles and multiple days, sug-
gesting system applicability for treatments that would
beneﬁt from repeated, pulsatile drug release [72].
Thus, SPION technologies can reduce the ther-
apeutic dosages administered, reduce the side effects
caused by higher dosages in systemic circulation,
decrease (undesired) diffusion into surrounding zones
and improve treatment efﬁciency. Moreover, magn-
etic carriers developed for bioactive agent delivery can
retain their ability to be imaged byMRI. Thus, the dis-
eased tissue can ﬁrst be located by conventional MRI
techniques and the incorporated agent monitored and
released as required (image guided therapy) [73].
The potential of SPION systems for targeted and
controlled drug delivery hasmainly been employed for
chemotherapeutic and radiotherapeutic delivery for
cancer treatment having reached the clinical stage
[74]. But the delivery of other drugs/biomolecules in
SPIONdelivery systems for diseases such as heart/car-
diac diseases [75], brain disorders [76, 77] are also
under study.
Furthermore, there is the possibility of incorporat-
ing multiple biomolecules with joined or sequential
release to modulate the particular cell response of a
given tissue. One example takes advantage of this
approach to study inﬂamed tissue and control inﬂam-
mation stages, which may be associated with the
mechanisms of disease.
The release of agents with biological relevance can
also contribute to the establishment of models to pre-
dict individual behaviours for a regimen involving a
single drug or a cocktail of drugs, scaling up the most
promising agents to clinics, and personalizing strate-
gies to hinder the progression of disease and envision
an optimized treatment for each patient.
3.4.Magnetofection and gene delivery
Magnetofection is deﬁned as the delivery of nucleic
acids, either ‘naked’ or packaged (as complexes with
lipids or polymers, and viruses) into the target cells
using MNPs under the guidance of an external MF
[78]. The advantage of magnetofection over other
transfection methods is its high efﬁciency, short-term
incubation protocols, low toxicity, and the avoidance
of using viral vectors, which are associated with
adverse immunogenic responses and mutagen-
esis [79, 80].
The cationic polymer polyethylenimine (PEI) is the
gold standard for nucleic acid magnetofection; how-
ever, it exhibits a well-known dose-dependent cyto-
toxicity [81]. SPIONs modiﬁed with cationic lipids or
polymers can bind electrostatically to a negatively
charged phosphate backbone of genetic material,
forming magnetic complexes to be transfected into
cells under the application of an MF [79, 82], integrat-
ing the genetic material of the cell, upregulating desir-
able genes and leading to the synthesis of therapeutic
proteins. An effective gene delivery and imaging system
to target hepatocytes has been developed by Cheong
et al [83] to help in the diagnosis and treatment of
liver diseases. SPIONs were loaded into chitosan-
conjugated linoleic acid nanoparticles and further
associated with a plasmid vector containing the
enhanced green ﬂuorescence protein (pEGFP). Lino-
leic acid was used to target the hepatocytes and chit-
osan to complex with the plasmid vector. The GFP
expression was detected in the cytoplasm of hepato-
cytes in vitro, and after an intravenous injection inmice
it was possible tomonitor the selective accumulation of
the nanoparticles in hepatocytes byMRI, allowing gene
mobility to be tracked.
Besides gene therapies, SPION technology can be
used in guiding cell processes such as lineage differ-
entiation (ﬁgure 3(c2)).
An interesting combined approach is ‘magselec-
tofection’, in which genetic modiﬁcation and cell iso-
lation are integrated in a single procedure proposed by
Sanchez-Antequera et al [84], combining magnetic
non-viral and viral vector compositions and MACS
columns. This technique was recently employed in the
application of magnetic cell sorting after hMSC trans-
fection with magnetic capsules (intracellular delivery
of messenger RNA). The magnetic sorting process
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allowed both hMSCs containing magnetic capsules
and hMSCs without magnetic capsules to be
obtained [85].
Successful cell programming with SPIONs is envi-
sioned to contribute to efﬁcient cell differentiation
protocols, establish proper in vitro models to better
understand the molecular mechanisms underlying
regeneration and assist the development of improved
regenerativemedicine strategies.
3.5.Magnetite-functionalized cells (cell sheets)
The integration of cell biology within nanomaterials
science results in highly speciﬁc approaches that can
result in smart responsive cell sheets, a new generation
of cell sheet technologies, as tissue substitutes. The
rationale of this approach is based on the fact that cells
synthesize their own tissue-speciﬁc extracellular
matrix (ECM) following structural and hierarchical
coordination, bypassing the need for artiﬁcial devices
and their shortfalls [86].
First termed ‘magnetic force-based tissue engi-
neering’ (Mag-TE), by Akira Ito and co-workers in
2004 [87], this concept names a construction techni-
que of magnetically labelled cell sheets, where magn-
etic force is applied to manipulate the attachment and
release of (ﬁgure 3(d)) an integrative and stable extra-
cellular rich layer of cells. Magnetic scaffold-free con-
structs are suggested as cohesive tissue-like matrices
for tissue augmentation capable of magnetic respon-
siveness and guidance upon implantation. In the study
proposed by Ito and co-authors [87], magnetite catio-
nic liposomes were taken up by keratinocytes to mag-
netically label the cells. The labelled cells were then
seeded in ultralow-attachment plates under a vertical
magnetic force provided by a neodymium magnet.
One day after, themagnet was removed and themagn-
etic keratinocyte sheets were harvested using a cylind-
rical alnicomagnet.
In another work performed by Shimizu and col-
leagues, this ‘Mag-TE’ technique was used to trans-
plant mesenchymal stem cell (MSC) sheets into a
cranial bone defect in nude rats using an electro-
magnet [88], resulting in new bone formation sur-
rounded by osteoblast-like cells in the area of the
defect. Ishii et al [89] also investigated the therapeutic
potential ofmagneticMSC sheets for reparative angio-
genesis in a mouse model of hind limb ischemia. Ani-
mals treated with magnetized MSC sheets placed on
top of the ischemic adductormuscles showed a greater
degree of blood perfusion, increased expression of vas-
cular endothelial growth factor (VEGF) and reduced
apoptosis in ischemic tissues [89] in comparison to
animals treated with injectedmagnetizedMSCs. Simi-
larly, magnetite cationic liposomes (MCL) were used
to magnetically label C2C12 myoblast cells for the
construction of three-dimensional artiﬁcial skeletal
muscle tissues by magnetic force [90, 91]. Herein,
MCL-labelled C2C12 cells were seeded into the gap
between the well wall and a polycarbonate cylinder,
and a magnet was placed under the well [91]. These
ring-shaped cellular constructs were subsequently
removed and hooked around two stainless-steel min-
utien pins. The fabricated constructs expressed myo-
genicmarkers during differentiation and contracted to
generate physical forces in response to electrical
stimulation.
More recently, Kito and colleagues investigated
the therapeutic potential of combining induced plur-
ipotent stem (iPS) technology with magnetic cell
sheets for reparative angiogenesis [92]. iPS cells gener-
ated from mouse skin ﬁbroblasts were induced in iPS
cell-derived fetal liver kinase-1 positive (Flk-1+), incu-
bated with MCLs and mixed with a diluted ECM pre-
cursor embedding system (type I collagen and
matrigel). Then, a magnet was placed on the reverse
side in order to form a multi-layered cell sheet. The
implantation of the magnetized iPS cell sheet acceler-
ated the revascularization of the ischemic hindlimbs
relative to the contralateral limbs in nude mice, with
increased expression of VEGF and bFGF in the
ischemic tissue [92].
In these studies, the potential to use magnetically
functionalized cells from different sources to con-
struct multi-layered cell sheets has been demonstrated
for different applications as musculoskeletal tissue
regeneration and vascularization using permanent
magnets that, by deﬁnition, generate static magnetic
ﬁelds which do not vary over time.However, the prop-
erties of a magnetic ﬁeld, such as strength/intensity
and exposure time, may result in a mechano-stimulus
effect at the cellular level. This effect is particularly
interesting for studies of musculoskeletal tissues and
may contribute to the understanding of mechan-
oresponsive processes in cells using magnetic force-
based tissue engineering. Gonçalves et al proposed a
biocompatible and bioinstructive extracellular-rich
patch made of a magnetically labelled cell sheet of a
subset of stem cells isolated from adipose tissue with
improved tenogenic capability, for the regeneration of
tenotopic defects [93]. The developed cell sheet exhib-
ited a tendon-like ECM, demonstrating goodmechan-
oelastic properties and magnetic responsiveness
capability, thus suggesting the applicability of these
scaffold free patches as augmentation tissue sub-
stitutes [93].
3.6.Magnetic responsive systems for tissue
engineering strategies
Strategies focusing on the development of magneti-
cally actuated biomaterials have been investigated for
tendon, bone, osteochondral, muscle, cardiac TE and
vascularization (table 1).
The rationale for using 3D architectures doped
with magnetic nanoparticles relies on the provision of
small stimulation point constituents of the scaffold’s
polymer/hydrogel matrix. This allows the scaffold to
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Table 1.Magnetic scaffolds onTE approaches, from 2010–2017.
Scaffold basematerial(s) Magnetic component(s)
Magnetization value
(emu g−1) Final application Reference
Hydroxyapatite (HA) and collagen Ferroﬂuids ofmagnetite nanoparticles coatedwith: dextransulfate and functionalizedwith sodium
sulfate functional groups (R- -OSO ,3 Na+); poly-DL-aspartic acid and functionalizedwith sodium
carboxylate (-COO−, Na+); starch and functionalizedwith phosphate groups.
0.14–15 Bone TE [94]
Poly (D,L-lactide) (PLA) and hydroxyapatite (HA) Nanoparticles of γ-Fe2O3 coatedwithmeso-2, 3-dimercaptosuccinic acid (DMSA) 0.0492 Bone TE [95]
Poly(ε-caprolactone) (PCL) Polyvinylpyrrolidone (PVP) coated Fe3O4 nanoparticles 3–6 Bone TE [96]
Poly(ε-caprolactone) (PCL) Superparamagnetic iron-doped hydroxyapatite (FeHA)nanoparticles 0.1–0.3 Bone TE [97]
Alginate Magnetite obtained from ferric chloride hexahydrate and ferrous chloride tetrahydrate 24 Vascularization [98]
Hydroxyapatite (HA) Magnetite powders 34 and 53 Bone TE [99]
Hydroxyapatite (HA) Magnetic nanoparticles colloids 0.24–0.94 Bone TE [100]
Poly(lactic-co-glycolic acid) (PLGA) Superparamagneticmagnetite nanoparticles 3.57–10.01 Bone TE [101]
Poly(ε-caprolactone) (PCL) and hydroxyapatite (HA) Iron-doped hydroxyapatite (FeHA)nanoparticles 0.2–1 Bone TE [102]
Poly(lactic-co-glycolide) (PLGA) Magnetic nanoparticles 0.54–5.46 AlignedTE [103]
Poly(ε-caprolactone) (PCL) Magnetic nanoparticles 1–11.2 Bone TE [104]
Gelatin–siloxane Magnetic nanoparticles 0.24–0.64 Bone TE [105]
Starch and polycaprolactone (SPCL) Iron oxide nanoparticles 1.22 TendonTE [106]
Poly(ε-caprolactone) (PCL) Iron(III) acetylacetonate 1.7 and 4.8 Bone TE [107]
Poly(ε-caprolactone) and poly(ethylene glycol) Magnetic nanoparticles — Osteochondral TE [108]
Poly(ε-caprolactone) (PCL) Iron oxide (Fe3O4) 0.2–1 Bone TE [109]











respond to the application of an external magnetic
ﬁeld, bymeans of its stimulating intrinsic components
[111]. It is thus undoubtedly advantageous to have this
additional scaffold function when it comes to provid-
ing local and controlled stimulation at the site of
injury, exploiting magnetic forces to improve implant
ﬁxation, and control tissue morphology along
regeneration.
The creation of a polymericmagnetic aligned scaffold
using the rapid prototyping technique (ﬁgure 3(e)) was
described by Gonçalves et al [106] for tendon tissue engi-
neering combining a blend of starch, polycaprolactone
and iron oxide MNPs. hASCs cultured onto the aligned
magnetic scaffolds resulted in the synthesis of a tenascinC
and collagen type I rich matrix in magneto-stimulation
conditions.
Yulia Sapir [98] also reported the development of
alginate scaffolds impregnated with magnetite, which
when combined with an alternating ﬁeld promoted
the organization of endothelial cells into capillary-like
structures in vitro. The same author further studied
the response of cardiac cells seeded onto these scaf-
folds [112]. Short-term stimulation of the cardiac cells
in anMNP-impregnated scaffold induced AKT activa-
tion by a factor of 1.8. Moreover, a three-fold greater
metabolic activity and increased protein levels of tro-
ponin-T and connexin-43 were observed in stimu-
lated cardiac cell constructs compared to the non-
stimulated ones.
Despite the wide range of applications investi-
gated, magnetic elements incorporated within 3D
matrices seem to improve the biofunctionality of the
tissue substitutes for TE applications [113]. Besides the
magnetic responsive polymer-based scaffolds, hydro-
gel matrices incorporating MNPs have also been
developed for musculoskeletal tissue engineering
[114, 115]. A photocrosslinkable magnetic responsive
hydrogel made of methacrylated chondroitin sulfate
(MA-CS) enriched with platelet lysate was reported to
modulate the growth factor release and swelling, as
well as having an impact on both the cell morphology
and the expression and synthesis of the tendon- and
bone-like matrix [114]. Cezar et al also reported the
remote magnetic actuation of biphasic ferrogel scaf-
folds composed of alginate with 7 wt% iron oxide
implanted in a mouse muscle model [116]. The exter-
nal magnetic ﬁeld resulted in uniform cyclic compres-
sions that led to reduced ﬁbrous capsule formation
and reduced ﬁbrosis and inﬂammation in the injured
muscle. Moreover, ferrogel-driven mechanical com-
pressions led to enhanced muscle regeneration and a
∼threefold increase in the maximum contractile force
of the treated muscle at two weeks compared with the
no-treatment controls.
With the advances of nanoplatforms in recent
years, SPION technology and magnetic actuated sys-
tems have arisen with elegant solutions for diagnosis
and attractive possibilities for regenerative strategies
and therapeutic approaches. Despite the promising
results and safety studies, some of the proposed
approaches require further validation before becom-
ing available to the clinical ﬁeld. With the exception of
SPIONs and ES-MIONPs used asMRI contrast agents,
the magnetic tools proposed for both diagnosis and
therapeutics are limited to research and development.
The cell-based studies performed with different
cell sources and soluble agents, including drugs and
bioactive molecules in magnetic actuated systems for
applications as diverse as cell tracking, monitoring or
promoting cellular mechanisms as proliferation, dif-
ferentiation and tissue regeneration justify the con-
tinuous improvement of these strategies and demand
translational development into clinics.
4. Future perspectives
It is anticipated that the growing investigation of
magnetic actuated strategies in the biomedical ﬁeld
and their promising results will have an impact on
human healthcare, from cell tracking and imaging
techniques to gene and drug screening, and contribute
to the identiﬁcation of biomolecular mechanisms and
the establishment of biological timelines in home-
ostasis and the progression of disease.
The versatility of SPION-based technologies in
isolating, screening and characterizing cell popula-
tions of therapeutic interest is encouraging the
research of newmedia for cell differentiation as well as
the identiﬁcation and characterization of cell subsets
within heterogeneous cellular pools. The availability
of cells with enhanced therapeutic value will likely
reduce the number of cells required for cell therapies
and the costs associated with isolation and culturing
methodologies in vitro.
Cells naturally respond to magnetic forces and to
the magnetic elements used for cell labelling. Since
magnetic parameters can be accurately controlled and
manipulated, the stimulation, maturation and func-
tionality of implantable cells with or without sophisti-
cated carriers and cargoes (such as genes or drugs)
enables the combinatorial effects and more predictive
outcomes of cell behaviour to a particular environ-
ment, including non-physiological/pathological con-
ditions. SPION-based technologies allow online
monitoring upon implantation, enabling a non-inva-
sive and real-time follow-up, providing information
on the success of a therapy and the welfare of the
patient. Thereupon, with this dual imaging/therapy
approach, treatment can be rapidly adjusted, if nee-
ded, manipulating the external magnetic ﬁeld, with
minimal discomfort or potential side effects.
Thus, SPION technologies will also advance the
ﬁeld of tissue engineering and regenerative medicine
(TERM), more speciﬁcallymagTERM, contributing to
the establishment of labelling and differentiation pro-
tocols, to the optimization of novel tools for gene or
protein screening and delivery, to the manipulation of
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therapeutic cells in the presence or absence of sophisti-
catedmatrices, which ultimately sustain repair and/or
regeneration, and enable remote controlled action
over tissue-engineered constructs in vitro and in vivo.
Therefore, strategies combiningmagnetically actuated
cells and/or magnetic responsive biomaterials would
lead to smartly instructive systems fully committed to
tissue substitution and regeneration, bolstering the
progress of regenerativemedicine strategies.
Magnetic actuated systems representmajor advan-
ces in the ﬁelds of nanomedicine and personalized
medicine, able to combine diagnostic agents and ther-
apeutic cues as powerful theranostic platforms of pre-
dictive action for clinical applications. The successful
achievements of such sophisticated tools with biologi-
cal signiﬁcance and personalized implications for tis-
sue healing and regeneration will pave the way for the
translation of novel biomedical technologies and will
assist the healthcare system with more sophisticated
and innovative therapies, contributing to the quality of
life of patients worldwide.
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